Journals / Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi / 2015 / Cilt: 61 - Sayı: 2

Romatoid Artritli Kadınlarda Alt Üriner Sisteme Ait Semptomların Görülme Sıklığı ve Yaşam Kalitesi Üzerine Olan Etkileri

Frequency of Lower Urinary Tract Symptoms and Effects on Quality of Life in Women with Rheumatoid Arthritis

Pages
99–105
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

QoL measurements were also significantly lower in this group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To investigate the frequency of lower urinary tract symptoms (LUTS) in women with rheumatoid arthritis (RA) and to evaluate its possible effects on quality of life (QoL).
📊
Key Findings & Data:Material and Methods: A total of 104 women diagnosed with RA, who were aged between 30 and 60 years, and 82 healthy women were included in this study.
💡
Conclusion & Impact:QoL measurements were also significantly lower in this group (p
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To investigate the frequency of lower urinary tract symptoms (LUTS) in women with rheumatoid arthritis (RA) and to evaluate its possible effects on quality of life (QoL). Material and Methods: A total of 104 women diagnosed with RA, who were aged between 30 and 60 years, and 82 healthy women were included in this study. We used the American Urological Association symptom index as the gold criteria in the evaluation of LUTS and QoL. Hospital Anxiety and Depression Scale was used to evaluate anxiety/depression levels, whereas disease activity scale (DAS-28) and Health Assessment Questionnaire (HAQ) were used to determine the disease activity levels. Results: There was no statistical difference between the two groups by means of age range. There was a prominent difference in LUTS frequency between the groups and moderate to severe symptoms were higher in women with RA. QoL measurements were also significantly lower in this group (p

Özet

Amaç: Romatoid artritli kadınlarda alt üriner sisteme ait semptomların (AUSS) sıklığını araştırmak ve bunun yaşam kalitesi (YK) üzerindeki etkilerini değerlendirmek. Gereç ve Yöntemler: Yaşları 30-60 arasında olan ve romatoid artrit tanısı almış olan toplam 104 kadın ve 82 sağlıklı bayan bu çalışmaya alındı. AUSS ve YKyi değerlendirmek için Amerikan Üroloji Derneği Semptom Endeksi (AUASI), anksiyete ve depresyon seviyelerini belirlemek için Hastane Anksiyete ve Depresyon Ölçeği (HADS) ve hastalığın etkinlik seviyesinin belirlenmesi için de DAS-28 ve Hastane Değerlendirme Anketi (HDA) altın ölçütler olarak belirlendi. Bulgular: İki grup arasında, yaş aralığı bakımından istatistiki fark yoktu. Gruplar arasında, AUSS görülme sıklığı bakımından belirgin bir farklılık vardı ve romatoid artritli kadınlardaki orta-ciddi seviyelerdeki belirtiler daha fazlaydı. Anksiyete ve depresyonla AUSS arasında pozitif korelasyon vardı (p

🔖

Cite This Article

İÇAĞASIOĞLU, A., ARAS, B., KOLUKISA, Ş., ARAS, H., DEMİRHAN, E., SELİMOĞLU, E., ÖCAL, E. E. (2022). Romatoid Artritli Kadınlarda Alt Üriner Sisteme Ait Semptomların Görülme Sıklığı ve Yaşam Kalitesi Üzerine Olan Etkileri. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, Cilt: 61 - Sayı: 2, 99–105. https://ajindex.com/articles/628717

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Gabriel SE. The epidemiology of rheumatoid arthritis. Rheum Dis Clin N Am 2001
  2. [CrossRef] 2. Turesson C, O’Fallon WN, Crowson CS, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 2003
  3. [CrossRef] 3. Terai A, Matsui Y, Ichioka K, Ohara H, Terada N, Yoshimura K. Comparative analysis of lower urinary tract symptoms and bother in both sexes. Urology 2004
  4. [CrossRef] 4. Yu HJ, Lee WC, Lee KL, Chen MY, Chen CY, Chen J. Voiding dysfunction in women with systemic lupus erythematosus. Arthritis Rheum 2004
  5. [CrossRef] 5. Walker J, Gordon T, Lester S, Downie-Doyle S, McEvoy D, Pile K, et al. Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjögren’s syndrome. J Rheumatol 2003
  6. Leppilahti M, Tammela TL, Huhtala H, Kiiholma P, Leppilahti K, Auvinen A. Interstitial cystitis-like urinary symptoms among patients with Sjogren’s syndrome: a population-based study in Finland. Am J Med 2003
  7. [CrossRef] 7. Haarala M, Alanen A, Hietarinta M, Kiiholma P. Lower urinary tract symptoms in patients with Sjogren’s syndrome and systemic lupus erythematosus. Int Urogynecol J Pelvic Floor Dysfunct 2000
  8. [CrossRef] 8. Goswami R, Seth A, Goswami AK, Kochupillai N. Prevalence of enuresis and other bladder symptoms in patients with active Graves disease. Br J Urol 1997
  9. [CrossRef] 9. Hocevar A, Tomsic M, Praprotnik S, Hojnik M, Kveder T, Rozman B. Parasympathetic nervous system dysfunction in primary Sjogren’s syndrome. Ann Rheum Dis 2003
  10. [CrossRef] 10. Guthrie RM, Siegel RL. A multicenter, community-based study of doxazosin in the treatment of concominant hypertension and symptomatic benign prostatic hyperplasia: the Hypertansion and BPH Intervential Trial (HABIT). Clin Ther 1999
  11. [CrossRef] 11. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983
  12. [CrossRef] 12. Prevoo ML, Van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twentyeight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995
  13. [CrossRef] 13. Küçükdeveci AA, Sahin H, Ataman S, Griffiths B, Tennant A. Issue in cross-cultural validity: example from the adaptation, reliability, and validity